Cyclobenzaprine
ADVERTISEMENT
- Molecular formula
- C20H21NO
- CAS Number
- 303-53-7
- IUPAC Name
- N,N-dimethyl-3-(7,8,9,10-tetrahydro-6H-cyclohepta[b]quinolin-11-yloxy)propan-1-amine
- Molecular Weight
- 275.39g/mol
- Melting Point
- (Celsius)
- Boiling Point
- (Celsius)
- Density
- 0.9220g/cm3
Identification
Interesting facts
Interesting Facts about N,N-Dimethyl-3-(7,8,9,10-tetrahydro-6H-cyclohepta[b]quinolin-11-yloxy)propan-1-amine
N,N-dimethyl-3-(7,8,9,10-tetrahydro-6H-cyclohepta[b]quinolin-11-yloxy)propan-1-amine is a fascinating compound that showcases the intricate relationship between organic chemistry and biological activity. Here are some engaging insights into this compound:
- Bioactivity: This compound is gaining attention for its potential biological activity, particularly in neuropharmacology. Compounds related to cyclohepta[b]quinoline structures often exhibit interesting interactions with neurotransmitter systems.
- Structural Complexity: The unique structure includes a multi-cyclic framework, which makes it an intriguing subject for chemists interested in medicinal chemistry. Its complex arrangement can lead to unique physiological effects.
- Applications in Research: Scientists are exploring derivatives of this compound for their potential use in drug development, particularly targeting neurological disorders, due to its structural analogs mimicking neurotransmitters.
- Synthetic Challenges: The synthesis of such sophisticated compounds requires advanced synthetic techniques, which can include multi-step protocols and the need for precise control over reaction conditions. This is an excellent example of the challenges chemists face in the lab.
- Future Directions: With ongoing research, this compound may pave the way for new treatments in areas such as depression and anxiety, where neurotransmitter modulation plays a crucial role.
This compound not only represents a complex organic molecule but also epitomizes the broader goals of medicinal chemistry to design and develop effective therapeutic agents.